January 19, 2017 7:00 PM ET

Biotechnology

Company Overview of OPKO Biologics

Key Executives for OPKO Biologics

NameBoard RelationshipsTitleAge
Abraham Havron Ph.D.71 RelationshipsChief Executive Officer and Director68
Shai Novik M.B.A.15 RelationshipsPresident, Director and Member of Governance Committee50
Steven Schaeffer CPANo RelationshipsChief Financial Officer and Principal Accounting Officer66
Fuad Fares D.Sc. 28 RelationshipsDirector and Chief Scientific Officer of Prolor Biotech Ltd61
Eyal Fima M.B.A., Ph.D.No RelationshipsChief Operating Officer of Prolor Biotech Ltd51

OPKO Biologics Board Members*

NameBoard RelationshipsPrimary CompanyAge
Philip Frost Phil, M.D., Ph.D. 157 RelationshipsOpko Health, Inc.80
Abraham Havron Ph.D. 71 RelationshipsOPKO Biologics68
Shai Novik M.B.A. 15 RelationshipsOPKO Biologics50
Fuad Fares D.Sc. 28 RelationshipsOPKO Biologics61
Steven D. Rubin J.D., Esq. 101 RelationshipsOpko Health, Inc.56
View All Board Members

OPKO Biologics Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee J.D., Esq.Steven D. Rubin101 Relationships2 Executives
Compensation Committee Phil, M.D., Ph.D.Philip Frost157 Relationships2 Executives
Corporate Governance Committee Phil, M.D., Ph.D.Philip Frost157 Relationships2 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary$270.0K
270.0K
369.7K
Bonus$60.0K
60.0K
261.6K
Total Short Term Compensation
Not meaningful
Total Value of Options$330.0K
330.0K
34.4M
Compensation as of Fiscal Year 2012
OPKO Biologics CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Kadmon Holdings, Inc. Announces Executive Changes
January 18, 2017 9:01 PM ET
TetraLogic Pharmaceuticals Corporation Appoints Alexandre Zyngier to Board of Directors and Management
January 18, 2017 6:36 PM ET
InMed Pharmaceuticals Inc. Announces to Retire Craig Schneider as Director
January 18, 2017 2:08 PM ET
Actinium Pharmaceuticals, Inc. Announces Executive Changes
January 18, 2017 1:00 PM ET
Merrimack Pharmaceuticals, Inc. Announces Executive Changes
January 18, 2017 12:30 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact OPKO Biologics, please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.